Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to help increase access to Human papillomavirus infection vaccinations globally.

The UK Government acknowledges the importance of Human papillomavirus (HPV) vaccinations in preventing deaths from cervical cancer. As the largest donor to Gavi's core mission contributing £1.65 billion to the Global Vaccine Alliance's (Gavi) 2021-2025 strategic period, the UK supports Gavi's efforts to accelerate the introduction, access and coverage of the vaccine in low- or middle-income countries (LMICs) with the aim of immunising 86 million more girls by 2025. Alongside our Gavi investment, we are committed to working with countries and with the wider international community to focus efforts on building stronger primary health systems for the future as a core part of increasing access to immunisation services around the world.